JAGSNPHARM investors hold onto their investments as it marginally outperforms
17 May, 20197 min read
JAGSNPHARM managed to marginally outperform the broader market today. On a longer term basis, investors in JAGSONPAL PHARMACEUTICALS made +0.11% per day. Friday's performance of +1.01% was a significant outperformance compared to it's daily average.
Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Symbol
Price
{{retType}}
|
Tr.
{{detail.symbol}}
{{detail.close}}
{{detail.priceChange}}
{{detail.pctChange}}%
{{detail.name}}
{{detail.trend}}
Share with friends 
